Drug Type Small molecule drug |
Synonyms- |
Target |
Action modulators |
Mechanism PKD1 modulators(polycystin 1, transient receptor potential channel interacting modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC24H20F2N6O2 |
InChIKeyIEYYCESJQBBVRP-UHFFFAOYSA-N |
CAS Registry3084684-94-3 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Polycystic Kidney, Autosomal Dominant | Preclinical | United States | 13 Jul 2025 |





